Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
Items 601–700 of 1,000
GH3B6 Pituitary Tumor Cell Proliferation is Mediated by PKCα and PKCε via ERK 1/2-dependent Pathway
Petiti, J. P., Gutiérrez, S., Paul, A. L. D., Andreoli, V., Palmeri, C. M., Sosa, L. D. V., Bocco, J. L., & Torres, A. I. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000320519 · Cited by 13
Basu, A., Sridharan, S., & Persaud, S. D. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.07.006 · Cited by 13
Masoumi, K. C., Cornmark, L., Lønne, G. K., Hellman, U., & Larsson, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.033 · Cited by 12
“The PKC isoforms and in particular the novel PKCd are known to regulate apoptotic pathways [9,10].”
BackgroundBessone, M. I. D., Berardi, D. E., Cirigliano, S. M., Delbart, D. I., Peters, M. G., Todaro, L. B., & Urtreger, A. J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03368-7 · Cited by 12
Impact of deleterious missense PRKCI variants on structural and functional dynamics of protein
Shah, H., Khan, K., Khan, N., Badshah, Y., Ashraf, N. M., & Shabbir, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-07526-4 · Cited by 13
Wang, J., Jin, J., Liang, Y., Zhang, Y., Wu, N., Fan, M., Zeng, F., & Deng, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.978840 · Cited by 12
“There is substantial evidence linking PKC to tumorigenesis (Griner and Kazanietz, 2007).”
BackgroundJust‐Borràs, L., Cilleros‐Mañé, V., Polishchuk, A., Balanyà-Segura, M., Tomàs, M., García, N., Tomàs, J. M., & Lanuza, M. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1069940 · Cited by 12
“FL-mediated PLCγ1 activation, mature PKCs are anchored to the membrane (Colón-González and Kazanietz, 2006; Griner and Kazanietz, 2007).”
BackgroundChen, Z., Chen, N., Fu, P., Wang, W., Bian, S., Zhang, H., Shen, S., & Han, B. (2023) · Molecules · doi:10.3390/molecules28062786 · Cited by 12
“Several ATXs were found to be activators of protein kinase C (PKC) [15,16], a vital therapeutic target for cancers [17], such as debromoaplysiatoxin (DAT) and 3-deoxy-DAT, probably owing to the dihydroxyvaleryl moiety in their structures, namely a recognition domain interacting with the PKCδ C1B domain in the form of…”
BackgroundJin, L., Mi, T., Wu, X., Wang, Z., Zhang, Z., Liu, J., Wang, Z., Wang, J., Li, M., Ren, C., et al. (2023) · Cancers · doi:10.3390/cancers15072023 · Cited by 12
“Since malignant tumor formation is due to uncontrolled cell division and proliferation, and its occurrence and development are a multi-step continuous process, the role of protein kinase in the progression of malignant tumors is extremely critical [17].”
BackgroundKawabata, A., Matsuzuka, T., Doi, C., Seiler, G., Reischman, J., Pickel, L., Ayuzawa, R., Nguyen, T. A., & Tamura, M. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20840 · Cited by 12
“The roles of the PKC family in cell growth, apoptosis, invasion and differentiation are known to occur by transduction of mitogenic signaling pathways.(8) The initial study showing that PKC is activated by phorbol esters suggested that PKCs are tumor promoters.”
BackgroundDevelopment of diacyltetrol lipids as activators for the C1 domain of protein kinase C
Mamidi, N., Gorai, S., Mukherjee, R., & Manna, D. (2012) · Molecular BioSystems · doi:10.1039/c2mb05452c · Cited by 12
Talukdar, D., Panda, S., Borah, R., & Manna, D. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp5044305 · Cited by 12
The Pursuit of Enzyme Activation: A Snapshot of the Gold Rush
Teng, M., Young, D. W., & Tan, Z. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01291 · Cited by 12
Friedel, R. H., Friedel, C. C., Bonfert, T., Shi, R., Rad, R., & Soriano, P. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072338 · Cited by 14
“Both DAG and PA play important roles as second messengers for mitogenic signals, and modulation of their levels by Dgk proteins has been proposed to be a potential mechanism in cancer [17].”
BackgroundRoles of Oxidized Diacylglycerol for Carbon Tetrachloride-induced Liver Injury and Fibrosis in Mouse
Takekoshi, S., Kitatani, K., & Yamamoto, Y. (2014) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.14030 · Cited by 13
Tu‐Sekine, B., & Raben, D. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21813 · Cited by 14
“Two lipids with well-documented signaling roles are diacylglycerol (DAG) and phosphatidic acid (PA) (English et al., 1996; Kazanietz, 2000; Fang et al., 2001; Baillie et al., 2002; Brose et al., 2004; Loewen et al., 2004; Griner and Kazanietz, 2007).”
BackgroundGutiérrez-Uzquiza, Á., Colón‐González, F., Leonard, T. A., Canagarajah, B. J., Wang, H., Mayer, B. J., Hurley, J. H., & Kazanietz, M. G. (2013) · Nature Communications · doi:10.1038/ncomms2834 · Cited by 12
“Chimaerin family members (α1-, α2-, β1-, and β2-chimaerin) act as effectors of tyrosine-kinases such as EGFR or Eph receptors and G-protein coupled receptors (GPCRs) [2, 6, 8, 9].”
Self-citationCellular and Molecular Mechanisms of Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01416-0 · Cited by 13
Correction: Mimicking p14ARF Phosphorylation Influences Its Ability to Restrain Cell Proliferation
Vivo, M., Ranieri, M., Sansone, F., Santoriello, C., Calogero, R., CALABRÒ, V., Pollice, A., & Mantia, G. L. (2013) · PLoS ONE · doi:10.1371/annotation/77e996e1-a18e-47a6-918b-801932929b28 · Cited by 12
Bessa, C., Loureiro, J. B., Barros, M. G. R. T., Isca, V. M. S., Sardão, V. A., Oliveira, P. J., Bernardino, R. L., Herman-de-Sousa, C., Costa, M. A., Correia‐de‐Sá, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065710 · Cited by 12
Zhou, Y., Wang, M., Yin, H., & Ai, S. (2017) · Microchimica Acta · doi:10.1007/s00604-017-2341-x · Cited by 11
Roux, A., Winnard, P. T., van Voss, M. R. H., Muller, L., Jackson, S. N., Hoffer, B. J., Woods, A. S., & Raman, V. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04685-4 · Cited by 11
“Other notable metastatic lesion lipid markers, along with the acylcarnitines, were potential broad spectrum signaling molecules, such as phosphatidylinositols and diacylglycerols [51, 52].”
BackgroundMulti‐omic profiling reveals an RNA processing rheostat that predisposes to prostate cancer
Stentenbach, M., Ermer, J. A., Rudler, D. L., Perks, K. L., Raven, S. A., Lee, R. G., McCubbin, T., Marcellin, E., Siira, S. J., Rackham, O., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317463 · Cited by 11
“Proteins implicated in prostate tumorigenesis such as protein kinase C (PKC) pan P bII (Kikkawa et al, 1983; Griner & Kazanietz, 2007), Ecadherin (Navarro et al, 1991; Perl et al, 1998; Padmanaban et al, 2019; Na et al, 2020) and eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1;…”
BackgroundTalman, V., Gateva, G., Ahti, M., Ekokoski, E., Lappalainen, P., & Tuominen, R. K. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.01.002 · Cited by 11
“As the first recognized receptor for the tumor-promoting phorbol esters, PKC became a popular target in cancer research already in 1980s, and vast evidence substantiates an important role for PKC in controlling processes linked to cell proliferation and apoptosis as well as tumor invasion and angiogenesis (Griner and…”
BackgroundInfluentialOncogenes and Signal Transduction
Grumolato, L., & Aaronson, S. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00002-0 · Cited by 11
Jäntti, M. H., Talman, V., Räsänen, K., Tarvainen, I., Koistinen, H. K., & Tuominen, R. K. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12419 · Cited by 11
Wu, Y., Bai, X., Li, X., Zhu, C., & Wu, Z. (2018) · Oncology Letters · doi:10.3892/ol.2018.9448 · Cited by 14
Li, J., Zhang, Z., Wang, J., Du, S., Yao, D., Cao, R., & Cui, S. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.03.007 · Cited by 11
Sphingomyelin biosynthesis: its impact on lipid metabolism and atherosclerosis
Jiang, X., Yeang, C., Li, Z., Chakraborty, M., Liu, J., Zhang, H., & Fan, Y. (2009) · Clinical Lipidology · doi:10.2217/clp.09.49 · Cited by 11
Ramos-Martínez, J. I., González-Riopedre, M., & Barcia, R. (2011) · The European Zoological Journal · doi:10.1080/11250003.2011.600729 · Cited by 11
“PKCs intervene in processes related to growth and cell differentiation, neuronal development, nervous transmission, muscle ISSN 1125-0003 print/ISSN 1748-5851 online © 2012 Unione Zoologica Italiana http://dx.doi.org/10.1080/11250003.2011.600729 contraction, apoptosis, cell aging, etc. (Simon et al. 1991; Oliva et al.…”
BackgroundInfluentialKim, K., Wang, L., & Hwang, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000752 · Cited by 11
The requirement for protein kinase C delta (PRKCD) during preimplantation bovine embryo development
Yang, Q., Ozawa, M., Zhang, K., Johnson, S., & Ealy, A. D. (2014) · Reproduction Fertility and Development · doi:10.1071/rd14160 · Cited by 11
“The PKC family is divided into three subfamilies based on structural similarities and commonality of responses (Griner and Kazanietz 2007).”
BackgroundNakagawa, R., Vukovic, M., Tarafdar, A., Cosimo, E., Dunn, K. M., McCaig, A. M., Holroyd, A. K., McClanahan, F., Ramsay, A. G., Gribben, J. G., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.112276 · Cited by 11
Lee, J., Park, I., Park, G., Cho, K., Park, H.-S., & Min, D. (2016) · Chemical Communications · doi:10.1039/c6cc05834e · Cited by 11
5-oxo-ETE activates migration of H295R adrenocortical cells via MAPK and PKC pathways
Neuman, I., Cooke, M., Lemiña, N. A., Kazanietz, M. G., & Maciel, F. C. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106346 · Cited by 11
“PKCs can be classified into classical cPKCs (calcium-dependent PKCα, βI, βII, and γ), novel nPKCs (calcium independent PKCδ, ε, η, and θ), and atypical aPKCs (DAG/ phorbol ester-insensitive, calcium-independent PKCζ and ι) [20].”
BackgroundSelf-citationA Review of Catalytic Upgrading of Biodiesel Waste Glycerol to Valuable Products
Li, X., Zhou, Q., Pan, S.-X., He, Y., & Chang, F. (2020) · Current Green Chemistry · doi:10.2174/2213346107666200108114217 · Cited by 11
Newton, A. C. (2008) · IUBMB Life · doi:10.1002/iub.118 · Cited by 11
Lipids: Driving Forces in the Underlying Biology of Carcinogenesis
Chakraborty, S., Kumar, A. S., & Banerjee, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00170 · Cited by 10
Liu, J., Ma, J., Zhang, Y., Li, J., Yang, Y., Yin, P., Wan, X., Ma, S., & Shang, D. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00805-8 · Cited by 11
“DAG then serves as a second messenger to activate downstream pathways involving protein kinase C (PKC), Ras guanine nucleotide-releasing proteins (RasGRPs), and protein kinase D (PKD), thereby regulating cell proliferation, differentiation, and immune responses [58–61].”
Jiang, Y., Saga, K., Miyamoto, Y., & Kaneda, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9105 · Cited by 10
“However, protein kinase C (PKC) [55], calpains activation and ER stress [54] were not the downstream events involved in Ca2+ level modification-induced apoptosis by HVJ-E (unpublished data).”
BackgroundDeciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells
Serrano-López, E. M., Coronado-Parra, T., Marín‐Vicente, C., Szállási, Z., Gómez-Abellán, V., López-Andreo, M. J., Gragera, M., Gómez-Fernández, J. C., López‐Nicolás, R., & Corbalán‐García, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214023 · Cited by 10
DNA damage targets PKCη to the nuclear membrane via its C1b domain
Tamarkin, A., Zurgil, U., Braiman, A., Hai, N., Krasnitsky, E., Maissel, A., Ben-Ari, A., Yankelovich, L., & Livneh, E. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.021 · Cited by 10
Gal, N., Kolusheva, S., Kedei, N., Telek, A., Naeem, T. A., Lewin, N. E., Lim, L., Mannan, P., Garfield, S. H., Kazzouli, S. E., et al. (2011) · ChemBioChem · doi:10.1002/cbic.201100246 · Cited by 10
Localization of PKC? in Cell Membranes as a Predictor for Breast Cancer Response to Treatment
Karp, G., Abu‐Ghanem, S., Novack, V., Mermershtain, W., Ariad, S., Sion‐Vardy, N., & Livneh, E. (2012) · Onkologie · doi:10.1159/000338443 · Cited by 10
Lu, H., Zhu, L., Lian, L., Chen, M., Shi, D., & Wang, K. (2015) · Tumor Biology · doi:10.1007/s13277-015-3182-z · Cited by 10
“Activated γPKC in the cytoplasm release autoinhibition and involves in cell proliferation, tumors migration and invasion, and survival of cancer cells [30, 31].”
BackgroundMamidi, N., Gorai, S., Ravi, B., & Manna, D. (2014) · RSC Advances · doi:10.1039/c4ra02495h · Cited by 10
Beyoğlu, D., Krausz, K. W., Martin, J., Maurhofer, O., Dorow, J., Ceglarek, U., Gonzalez, F. J., Dufour, J., & Idle, J. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m050682 · Cited by 10
Synthetic Lethality Induced by Loss of PKC and Mutated Ras
Zhu, T., Chen, L., Du, W., Tsuji, T., & Chen, C. (2010) · Genes & Cancer · doi:10.1177/1947601909360989 · Cited by 10
“PKC regulates diverse cellular activities, including proliferation, differentiation, and apoptosis.(1,7,36) Studies showed that PKC family members are positively or negatively involved in the regulation of apoptosis induced by death receptors, genotoxic agents, anticancer drugs, and cell toxins.”
BackgroundBiological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin
Kelsey, J. S., Cataisson, C., Chen, J., Herrmann, M. A., Petersen, M. E., Baumann, D. O., McGowan, K. M., Yuspa, S. H., Keck, G. E., & Blumberg, P. M. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22460 · Cited by 10
“Protein kinase C (PKC) is a validated therapeutic target for cancer [1,2].”
BackgroundCai, Z., Yu, C., Li, S., Wang, C., Fan, Y., Ji, Q., Chen, F., & Li, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.685823 · Cited by 12
Loss of Diacylglycerol Kinase α Enhances Macrophage Responsiveness
Manigat, L. C., Granade, M. E., Taori, S., Miller, C. A., Vass, L. R., Zhong, X., Harris, T. E., & Purow, B. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722469 · Cited by 12
“In addition to being important regulators of a diverse set of cellular processes, PKCs have also been linked to tumorigenesis (2, 3).”
BackgroundHeinonen, S., Lautala, S., Koivuniemi, A., & Bunker, A. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.183961 · Cited by 10
Lai, X., Liang, Y., Jin, J., Zhang, H., Wu, Z., Li, G., Wang, J., Zhang, Z., Chen, H., Zeng, F., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113427 · Cited by 10
The unique protein kinase Cη: Implications for breast cancer (Review)
Pal, D., & Basu, A. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2443 · Cited by 10
Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Burns, T. A., & Luberto, C. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797655140 · Cited by 10
The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
Heckman, C. A., Pandey, P., Cayer, M. L., Biswas, T., Zhang, Z., & Boudreau, N. S. (2017) · Cytoskeleton · doi:10.1002/cm.21373 · Cited by 11
“…site in the activation loop is essential for maturation to the competent form and is preceded or followed by phosphorylation of two sites near the C-terminal end of the molecule (Keranen, Dutil, & Newton, 1995; Lachmann, Bär, Rommelaere, & N€uesch, 2008), [reviewed in (Griner and Kazanietz, 2007)].”
BackgroundInfluentialβ-Arrestin2 directly or through GRK2 inhibits PKCβII activation in a ubiquitination-dependent manner
Zhang, X., Zheng, M., Sun, N., & Kim, K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.10.009 · Cited by 10
“To date, PKC translocation to the plasma membrane has been generally considered as a hallmark of activation [28], and PKC autophosphorylation is established to be required for its translocation toward the plasma membrane in response to PKC activators [24, 25].”
BackgroundSudigyo, D., Rahmawati, G., Setiasari, D. W., Poluan, R. H., Sesotyosari, S., Wardana, T., Herawati, C., Heriyanto, D., Indrasari, S. R., Afiahayati, et al. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.9.2763 · Cited by 11
“PKC also functions as the main receptor for phorbol esters, tumor promoter class (Griner and Kazanietz, 2007).”
BackgroundCarlsón, K., & Ehrich, M. F. (2008) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20229 · Cited by 10
Role of protein kinase C delta in X‐ray‐induced apoptosis of keratinocyte
Lee, Y., Sohn, K., Kim, K., Cho, M., Hur, G. M., Yoon, T., Kim, S. K., Lee, K., Lee, J., & Kim, C. D. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00761.x · Cited by 10
Multifractality in Surface Potential for Cancer Diagnosis
Huynh, P. K., Nguyen, D. H., Binder, G. A., Ambardar, S., Le, T., & Voronine, D. V. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01733 · Cited by 9
“ovarian cancer based on the overexpression of certain proteins such as the protein kinase C (PKC) family [59, 60].”
BackgroundGlover, K., Markell, L. K., Donner, E. M., & Han, X. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.06.030 · Cited by 10
Provenzani, R., Tarvainen, I., Brandoli, G., Lempinen, A., Artes, S., Turku, A., Jäntti, M. H., Talman, V., Yli‐Kauhaluoma, J. T., Tuominen, R. K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195668 · Cited by 9
Yang, M., Liao, C.-C., Hung, J.-H., Lai, X.-T., Yen, C., & Chen, Y. A. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.12.007 · Cited by 9
“regulates various cellular processes including mitogenesis, proliferation, apoptosis, survival and migration as well as tumorigenesis [23].”
BackgroundThe total synthesis of (−)-indolactam I
Mendoza, M., Rao, N., Tran, U. C., Castaneda, C., & Billingsley, K. L. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.04.069 · Cited by 9
Isca, V. M. S., Bangay, G., Princiotto, S., Saraiva, L., dos Santos, D. J. V. A., García‐Sosa, A. T., & Rijo, P. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-67384-0 · Cited by 9
“This complexity poses challenges in designing selective PKC modulators 8,16,17 .”
BackgroundKiriazis, A., af Gennäs, G. B., Talman, V., Ekokoski, E., Ruotsalainen, T., Kylänlahti, I., Rüffer, T., Wissel, G., Xhaard, H., Lang, H., et al. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.09.044 · Cited by 9
Gürbüz, N., Park, M., Dent, P., Mageed, A. A., Sikka, S. C., & Baykal, A. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666141120121901 · Cited by 13
“However, it is not known whether tumor promotion results from PKC isozyme activation, or depletion of PKC isozymes due to chronic activation [3].”
BackgroundChen, H.-T., Sun, D., Peng, Y., Kao, P., & Wu, Y.-L. (2016) · Innate Immunity · doi:10.1177/1753425916676347 · Cited by 9
“Previous studies have noted that PKC expression is elevated in human breast tumors compared with normal breast tissue, and many researchers have also shown that PKC participates in cancer proliferation, invasion, metastasis and angiogenesis.(37,38) In the current study, TPA was used to activate the PKC signaling pathw…”
MethodCheng, Y.-W., Chen, K.-W., Kuo, H., Kuo, C., Lin, W., Chen, P., & Yeh, S. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0431-z · Cited by 9
A supramolecular host for phosphatidylglycerol (PG) lipids with antibacterial activity
Williams, E. S., Gneid, H., Marshall, S. R., González, M. J., Mandelbaum, J. A., & Busschaert, N. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob02298a · Cited by 9
Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3281 · Cited by 9
Detection of CREB phosphorylation via Zr (IV) ion mediated signal amplification
Yin, T., Li, H., Yang, N., Gao, T., Sun, L., & Li, G. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.12.057 · Cited by 9
Chu, P., Hsu, N. C.-H., Tai, H., Yeh, C., Lin, S., Hou, M., & Yeh, K. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.05.001 · Cited by 9
β3-Chimaerin, a novel member of the chimaerin Rac-GAP family
Zubeldía-Brenner, L., Gutiérrez-Uzquiza, Á., Barrio‐Real, L., Wang, H., Kazanietz, M. G., & Leskow, F. C. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3055-3 · Cited by 9
“Binding of DAG or DAG mimetics (such as phorbol esters) to the C1 domain leads to allosteric activation of the protein which, in response to various stimuli, results in deactivation of the Rac GTPase [9–11].”
BackgroundSelf-citationSingh, A. K., Singh, A., Sand, J. M., Héninger, E., Hafeez, B. B., & Verma, A. K. (2013) · Journal of Skin Cancer · doi:10.1155/2013/452425 · Cited by 10
“A major breakthrough in understanding the mechanism of TPA tumor promotion has been the identification of protein kinase C (PKC), as its major intracellular receptor [3].”
BackgroundWong, C. A., Jiang, H., Abel, P. W., Scofield, M. A., Xie, Y., Wei, T., & Tu, Y. (2016) · Protein & Cell · doi:10.1007/s13238-016-0261-x · Cited by 9
“PMA itself has both oncogenic and antitumorigenic properties by direct or indirect modulation of various cellular targets (Griner and Kazanietz, 2007).”
Establishment of a novel hepatic steatosis cell model by Cas9/sgRNA-mediated DGKθ gene knockout
Zhang, J., Zhao, J., Zheng, X., Cai, K., Mao, Q., & Xia, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8140 · Cited by 12
“Diacylglycerol kinases (DGKs) are endogenous lipid regulation enzymes, which are involved in multiple cellular signaling pathways by regulating the levels of intracellular secondary messengers diacylglycerol (DAG) and phosphatidyl acid (PA) (1,2).”
LeY oligosaccharide upregulates DAG/PKC signaling pathway in the human endometrial cells
Li, Y., Ma, K., Sun, P., Liu, S., Qin, H., Zhengmei, Z., Wang, X., & Yan, Q. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0137-y · Cited by 9
“It is an upstream signaling molecule of PKC [29].”
BackgroundBedford, L. M., Tutrow, K. D., Hooper, K., Messenger, E. J., Hernandez, M., Lamb, B. T., Meyer, J. S., Richardson, T. I., & Bissel, S. J. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70772 · Cited by 10
Zhang, S., Xu, Y., Zeng, L., An, X., Su, D., Qu, Y., Ma, J., Tang, X., Wang, X., Yang, J., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00401 · Cited by 8
Pany, S., Majhi, A., & Das, J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00057 · Cited by 8
“maxima of curcumin (1) and its derivatives (2-6) in various solvents.”
BackgroundMethodInfluentialMarca, J. E. L., Ely, R. W., Diepstraten, S. T., Burke, P., Kelly, G. L., Humbert, P. O., & Richardson, H. E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049769 · Cited by 9
Chu, P., Hsu, N. C.-H., Lin, S., Hou, M., & Yeh, K. (2012) · PubMed · Cited by 8
Ham, S. W., Jeon, H.-Y., & Kim, H. (2017) · Tumor Biology · doi:10.1177/1010428317692244 · Cited by 8
Von Hippel-Lindau regulates interleukin-32β stability in ovarian cancer cells
Yong, H. J., Park, J. S., Jeong, A. L., Han, S., Lee, S., Ka, H. I., Sumiyasuren, B., Joo, H. J., So, S. J., Park, J. Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19311 · Cited by 8
“The protein kinase C (PKC) family comprises serine/threonine kinases that regulate a diverse set of cellular processes including proliferation, apoptosis, survival, and migration, and there is a substantial amount of evidence linking PKC to tumorigenesis [23].”
BackgroundProfiling the interactome of protein kinase C ζ by proteomics and bioinformatics
Hou, C., Li, Y., Liu, H., Dang, M., Qin, G., Zhang, N., & Chen, R. (2018) · Proteome Science · doi:10.1186/s12953-018-0134-8 · Cited by 8
“Based on their distinct features, PKCs can be divided into three subtypes [4]: the conventional or classic PKCs, such as PKC α, β, γ; the novel PKCs, such as PKCδ, ε, η, θ, and the atypical PKCs, including PKCζ and PKCλ.”
El-Sisi, M. G., Radwan, S. M., Saeed, A. M., & EL-Mesallamy, H. O. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-04030-z · Cited by 8
Comin, M. J., Czifra, G., Kedei, N., Telek, A., Lewin, N. E., Kolusheva, S., Velasquez, J. F., Kobylarz, R., Jelinek, R., Blumberg, P. M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900186m · Cited by 8
Kim, Y.-R., Byun, H. S., Jeon, J., Choi, B. L., Park, K. A., Won, M., Zhang, T., Shin, S., Lee, H., Oh, J., et al. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9189-1 · Cited by 8
“In G1/S transition phase, PKCs activation has a negative regulatory role in the cell cycle by indirectly affecting the activity of the cyclin-dependent kinase (Cdk2)-cyclin complexes and the phosphorylation status of retinoblastoma Rb-protein [4, 5].”
BackgroundAnn, J., Czikora, Á., Saini, A. S., Zhou, X., Mitchell, G. A., Lewin, N. E., Peach, M. L., Blumberg, P. M., & Lee, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00661 · Cited by 8
Larsson, C. U. (2008) · Biochemical Journal · doi:10.1042/bj20080373 · Cited by 8
Shi, Y., Yang, Q., Xu, B., Yuan, C., Qi, K., Pan, Y., Wang, Z., Chen, Q., Sun, D., Zhao, W., et al. (2025) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00505 · Cited by 8
Li, A., Umphress, B. A., Dehner, C. A., Jones, R., Toral, K., Warren, S., & Alomari, A. K. (2025) · Journal of Cutaneous Pathology · doi:10.1111/cup.14801 · Cited by 7
Protein kinase Cα suppresses the expression of STC1 in MDA-MB-231 breast cancer cells
Cornmark, L., Lønne, G. K., Jögi, A., & Larsson, C. (2011) · Tumor Biology · doi:10.1007/s13277-011-0205-2 · Cited by 7
“These include the protein kinase C (PKC) family of isoforms [1, 2].”
BackgroundBilayer interaction and protein kinase C-C1 domain binding studies of kojic acid esters
Borah, R., Talukdar, D., Gorai, S., Bain, D., & Manna, D. (2014) · RSC Advances · doi:10.1039/c4ra02352h · Cited by 7
Protein kinase Cλ/ι in cancer: a contextual balance of time and signals
Moscat, J., Linares, J. F., Durán, Á., & Díaz-Meco, M. T. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.04.002 · Cited by 7
Celeste, F., & Powers, S. (2024) · Cancers · doi:10.3390/cancers16051001 · Cited by 8
Tan, J., Xiao, A., Yang, L., Tao, Y., Shao, Y., & Zhou, Q. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i3.519 · Cited by 8
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.